Lotus Tissue Repair secures $26 million in Series A financing

06/30/2011 | Mass High Tech (Boston)

Lotus Tissue Repair has secured $26 million in a Series A financing round, allowing it to launch as a spinoff of Third Rock Ventures. The startup will use the money to develop a proprietary recombinant collagen type VII technology into a collagen-based treatment for dystrophic epidermolysis bullosa, a rare skin disease. The University of Southern California licensed the technology to Lotus.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY